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Abstract
Purpose: To assess the respective involvement of retina versus choroid in presumed ocular tuberculosis (POT) 
in a non‑endemic area using dual fluorescein (FA) and indocyanine green angiography (ICGA).
Methods: We retrospectively analyzed cases diagnosed with POT at the Centre for Ophthalmic Specialized 
Care, Lausanne, Switzerland. Angiography signs were quantified using an established dual FA and ICGA 
scoring system for uveitis.
Results: Out of 1739 uveitis patients visited from 1995 to 2014, 53 (3%) were diagnosed with POT; of 
whom 28 patients (54 eyes) had sufficient data available to be included in this study. Of 54 affected eyes, 
39 showed predominant choroidal involvement, 14 showed predominant retinal involvement and one 
had equal retinal and choroidal scores. Mean angiographic score was 6.97 ± 5.08 for the retina versus 
13.48 ± 7.06 for the choroid (P < 0.0001). For patients with sufficient angiographic follow‑up after combined 
anti‑tuberculous and inflammation suppressive therapy, mean FA and ICGA scores decreased from 
6.97 ± 5.08 to 3.63 ± 3.14 (P = 0.004), and 13.48 ± 7.06 to 7.47 ± 5.58 (P < 0.0001), respectively.
Conclusion: These results represent the first report of the respective contributions of retinal and choroidal 
involvement in POT. Choroidal involvement was more common, for which ICGA is the preferred 
examination. In cases of compatible uveitis with positive results of an interferon‑gamma release assay, 
particularly in a region that is non‑endemic for TB, dual FA and ICGA should be performed to help establish 
the diagnosis of ocular tuberculosis and improve follow‑up.
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INTRODUCTION
Tuberculosis (TB) represents a major public health 
problem, with 9.6 million new cases diagnosed 
worldwide in 2014.[1] While TB most commonly affects 
pulmonary structures, extra‑pulmonary involvement is 
reported in 20–40% of cases.[2] In a minority of cases with 
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extra‑pulmonary involvement, TB involves structures of 
the eye.[3,4] Within endemic areas, such as India,[5] ocular 
tuberculosis typically presents in the active infectious 
form. On the other hand, in non‑endemic areas—such 
as Switzerland, which has only an estimated 550 new 
cases per year[6]—patients with ocular tuberculosis tend 
to present a subacute or indolent type of inflammation 
thought to be caused by an immunologic reaction against 
Mycobacterium tuberculosis[7] or other mycobacteria[8] 
rather than by the infection itself.[9‑12] This immune 
reaction develops against mycobacterial antigens present 
in tissues, such as the pigment epithelium, which is a 
sanctuary in which antigens concentrate.[13] Since ocular 
tuberculosis is rare in non‑endemic areas and because 
its clinical features are not pathognomonic, diagnosis is 
easily missed or substantially delayed.[3]
In recent years, new diagnostic modalities have 
become available to the uveitis specialist contributing 
to improvement in the diagnosis of ocular tuberculosis. 
In addition to the Purified Protein Derivative (PPD) or 
Mantoux test, interferon‑gamma release assays (IGRAs) 
is an important progress. Negative IGRA result excludes 
tuberculosis, but a positive result prompts the clinician to 
verify whether there is an active ocular tuberculosis by 
determining if there is ongoing disease characterized by 
a compatible uveitis including fundus foci, fundus scars, 
retinal vasculitis and papillitis or the result is indicative 
of only a latent inactive prior contact with M. tuberculosis 
or other mycobacteria. Our ability to detect previously 
subclinical and occult choroiditis has been substantially 
increased by newly available procedures for investigating 
the posterior segment of the eye,[14‑16] including choroidal 
optical coherence tomography (OCT)[17] and indocyanine 
green angiography (ICGA).[7,18‑23] These advancements 
may lead to substantial increase in the sensitivity of 
ocular tuberculosis diagnosis.
Prior studies have reported the use of clinical fundus 
examination and fluorescein angiography (FA) to 
describe retinal involvement in ocular tuberculosis.[24] 
However, these studies could not determine choroidal 
involvement or the proportion of retinal versus 
choroidal disease, as no reliable method was available 
to assess choroiditis. This is now possible with the 
use of ICGA. Thus, in our present study, we aimed 
to determine the degree of angiographic retinal 
involvement using FA, and the amount of choroidal 
involvement by ICGA, as well as the proportion of each 
versus the other.
METHODS
For this study, we reviewed the charts of patients 
seen at the uveitis clinic in the Centre for Ophthalmic 
Specialized Care (COS), Lausanne, Switzerland between 
1995 and 2014. We identified and retrospectively 
examined the files of patients diagnosed with presumed 
ocular tuberculosis. We excluded cases of serpiginoid 
choroiditis associated with a positive IGRA test, which 
is considered a phenotypically different entity with a 
diverse physiopathology.
Diagnosis and Treatment
Ocular tuberculosis was diagnosed in cases showing a 
compatible clinical presentation including fundus foci, 
fundus scars, retinal vasculitis and papillitis, together with 
a positive IGRA test and/or a hyper‑positive (>15 mm 
induration) PPD skin test using a Mantoux test with 
2 units tuberculin. The study included patients presenting 
with tuberculous chorioretinitis for whom results of 
dual FA/ICGA angiographic were available. In these 
patients, follow‑up data after treatment completion were 
analyzed. Standard anti‑tuberculous treatment (ATT) 
for ocular tuberculosis comprised four‑drug therapy for 
two months, three‑drug therapy for four months, and 
two‑drug therapy for six months.
Clinical Work-up
All included patients underwent the complete routine 
work‑up for patients with uveitis. Each major visit 
included a complete ocular examination (Snellen visual 
acuity, slit‑lamp examination, applanation tonometry, 
and funduscopy with mydriasis) as well as laser flare 
photometry (LFP), computerized visual field (VF) testing, 
optical coherence tomography (OCT) once available, and 
dual FA and ICGA.
Laser Flare Photometry, Optical Coherence 
Tomography, and Visual Field Testing
Laser flare photometry was performed using a Kowa 
FM‑500 or Kowa FM‑700 (Kowa Company, Ltd., 
Electronics and Optics Division, Tokyo, Japan). OCT 
was performed using an OTI‑Spectral OCT/SLO (OTI 
Inc., Toronto, Canada) or Heidelberg Spectralis 
OCT (Heidelberg Engineering, Inc., Heidelberg, 
Germany). For VF assessment, we used the G1 program 
of the Octopus 900, G Standard (Haag‑Streit, Bern, 
Switzerland).
Angiography
FA and ICGA were performed using a previously 
described standard protocol.[25] Briefly, FA and ICGA 
were usually performed simultaneously. Images were 
acquired using a Topcon 50 IA camera (Tokyo, Japan) 
coupled to an ImageNet (Topcon) image digitalizing 
system or a Heidelberg Retina Angiograph HRA 2 
(Heidelberg Engineering, Inc., Heidelberg, Germany). 
To exclude autofluorescence, pre‑injection fluorescence 
was determined with the highest flash intensity used for 
ICGA. At the same time, we acquired red‑free posterior 
pole frames.
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We performed a bolus injection of 4 mg of indocyanine 
green (ICG) (Cardiogreen; Peaselt, Lorei, Germany) 
diluted in 5 ml of an aqueous solution, and then 
ICGA frames of the posterior pole were acquired over 
approximately 2–3 minutes (early‑phase angiogram). At 
12 ± 3 minutes after ICG injection (intermediate‑phase 
ICGA angiogram) frames of the posterior pole, and a 
minimum of eight frames from the whole periphery 
over 360° were acquired for detailed analysis. At the 
end of the ICGA intermediate phase, we performed 
fluorescein angiography. For up to 2 minutes, we 
took early fluorescein angiographic frames of the 
posterior pole. Between 4 to 7 minutes, we performed 
360° panorama imaging of the periphery (minimum 
of eight frames), and at 10 minutes we acquired late 
fluorescein posterior pole frames. At 24 ± 4 minutes after 
ICG injection, we captured the late ICG fluorescence 
pattern (late‑phase ICGA angiogram) in the same 
manner as in the intermediate phase.
Angiographic Score
FA and ICGA were evaluated using an established 
dual FA/ICGA scoring system slightly modified for 
granulomatous chorioretinitis.[26,27] Briefly, a total 
maximum score of 40 was assigned to eight FA items 
including: (1) Optic disc hyperfluorescence (maximal 
score [MS] = 3), (2) macular edema (MS = 4), 
(3) retinal vascular staining and/or leakage (MS = 7), 
(4) capillary leakage (MS = 10), (5) retinal capillary 
nonperfusion (MS = 6), (6) optic disc neovascularization 
(MS = 2)/neovascularization elsewhere (MS = 2), 
(7) pinpoint leaks at the posterior pole (MS = 2), 
(8) retinal staining and/or subretinal pooling (MS = 4). 
A total maximum score of 40 was also assigned to 
four ICGA signs including: (1) Early stromal vessel 
hyperfluorescence (MS = 3), (2) fuzziness/exudation 
of choroidal vessels (MS = 6), (3) hypofluorescent dark 
dots or areas (excluding atrophy) (MS = 8), (4) optic disc 
hyperfluorescence and/or peripheral hyperfluorescent 
pinpoints (MS = 3). Each of the four ICGA items counted 
double versus the eight FA items to ensure that the scores 
reflected equivalent importance of involvement in both 
the retinal and choroidal compartments.
Angiographic data were analysed by an experienced 
angiographic specialist (CPH) in a masked fashion, 
names of patients being hidden to the examiner.
Outcome Measures
We calculated the mean patient age, mean time to 
diagnosis, mean duration of TB treatment, and the 
proportion of presumed ocular tuberculosis patients 
relative to the whole collective of uveitis patients. We 
determined the average angiographic score before and 
after anti‑tuberculous treatment, as well as best‑corrected 
visual acuity (BCVA), intraocular pressure (IOP), laser 
flare photometry (LFP), and the FA and ICGA scores 
for all eyes. We determined the number of cases with a 
predominance of retinal involvement versus choroidal 
involvement, and vice versa. Finally, we calculated the 
number of cases with occult chorioretinal lesions visible 
only on ICGA or FA. Comparisons were made using 
paired t‑test.
The study was approved by the IRB, and was 
performed in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki and its later 
amendments or comparable ethical standards. For this 
type of study, formal consent is not required and no 
funding was received for this research.
RESULTS
A total of 1739 patients with uveitis were seen at the 
Centre for Ophthalmic Specialized Care (COS) from 1995 
to 2014. Among these cases, we identified 53 (3%) charts 
with the diagnosis of presumed ocular tuberculosis. 
Out of these 53 subjects, 28 patients (54 eyes) with 
chorioretinitis fulfilled the inclusion criteria for our study. 
In two patients, only one eye could be evaluated. Patients 
included 12 female and 16 male subjects, with a mean 
age of 45.43 ± 17.03 years. Mean diagnostic delay (time 
interval between onset of symptoms and diagnosis) was 
58.39 ± 80.33 months, with a median of 24 months. Mean 
duration of treatment was 10.28 ± 4.16 months.
Mean BCVA was 0.82 ± 0.39 (Snellen VA) at 
presentation, increasing to 0.95 ± 0.36 after treatment 
(P = 0.0002, paired t‑test). Mean IOP was well within the 
normal range before (14.7 mmHg) and after treatment 
(14.6 mmHg) (P = 0.3, NS). Intraocular inflammation 
measured with laser flare photometry showed a 
mean flare of 27.06 ± 29 (ph/ms) at presentation, 
which decreased to 22.09 ± 32.03 after treatment 
(P = 0.1, NS). Fifteen patients presented with an anterior 
granulomatous uveitis showing granulomatous keratic 
precipitates and/or Koeppe nodules, while thirteen 
patients had a non‑granulomatous uveitis.
Fundus Examination
Fundus examination revealed no choroidal fundus foci 
in 8 patients (2 of whom had severe papillitis), active 
choroidal foci in 15 cases, and a mixture of choroidal 
scars and active foci in 4 subjects. One case exhibited an 
isolated tuberculoma. Five patients showed pronounced 
papillitis; as an isolated fundus finding in two subjects 
and in association with fundus foci in three cases. 
Isolated papillitis was associated with occult choroidal 
involvement seen on ICGA in both cases, explaining 
the origin of the papillitis. All patients had some degree 
of vitritis. Clinical vasculitis was present in 14 patients 
being bilateral in two. Vasculitis was proliferative in four 
cases and one patient had disc neovessels.
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Angiographic Findings
The type of angiographic device used did not influence 
the results. The most frequent FA sign (optic disc 
hyperfluorescence) and the most frequent ICGA 
sign (fuzziness/exudation of choroidal vessels) were 
compared between the Topcon and Heidelberg devices, 
showing no statistical difference, indicating that there 
was no bias whether one or the other instrument was 
used.
Dual FA/ICGA angiographic scoring enabled us 
to establish the proportion of retinal versus choroidal 
involvement. Mean of FA and ICGA scores of both 
eyes were calculated for each patient and the mean 
FA and ICGA scores were compared in each patient: 
In 19 patients, the ICGA score was higher than the FA 
score, in 8 patients the FA score was higher than the 
ICGA score and in one patient FA and ICGA scores 
were equal.
Considering all 54 examined eyes, 39 (72%) 
had predominant choroidal lesions, 14 (26%) had 
preponderant retinal lesions, and one (2%) had equal 
retinal and choroidal scores [Figure 1].
In four (14%) patients, diagnosis of ocular tuberculosis 
would have been missed if only FA had been performed, 
as the FA score was less than three (background 
inflammation), while the ICGA scores of these patients 
were 9, 13, 14, and 15. On the other hand, two (7%) 
patients would not have been diagnosed properly if only 
ICGA had been performed, as they had ICGA scores 
of less than three, while their FA scores were 13 and 9.
With regard to mean angiographic scores, choroidal 
involvement was significantly more important than 
retinal involvement [13.48 ± 7.06 versus 6.97 ± 5.08 
(P < 0.0001)] [Figure 2].
FA revealed that the preponderant lesions in the 54 
analyzed eyes were disc hyperfluorescence (N = 48, 89%) 
[Figure 3], peripheral capillary leakage at 5–10 minutes 
(N = 37, 69%), macular hyperfluorescence (N = 31, 57%), 
and posterior pole capillary leakage at 5–10 minutes 
(N = 30, 56%) [Figure 4]. Eighteen (33%) eyes showed 
peripheral retinal vascular staining and/or leakage. 
Eleven (20%) eyes showed retinal vascular staining 
and/or leakage at and around posterior pole arcades at 
5–10 minutes [Figure 4]. Retinal capillary non‑perfusion 
was observed in 7 (13%) eyes, and neovascularization 
elsewhere (NVE) in 7 (13%) eyes [Figure 5]. Rare features 
included retinal staining and/or subretinal pooling at 
5–10 minutes (N = 1, 2%) and neovascularization of 
the optic disc (NVD) (N = 1, 2%). Figure 6 shows the 
distribution of FA lesions.
ICGA results of the 54 eyes revealed that the most 
frequent lesions were fuzziness/exudation of choroidal 
vessels (N = 49, 91%) [Figure 7]; hypofluorescent dark 
dots (HDDs) in the mid‑periphery and periphery, 
evaluated in four quadrants (N = 45, 83%) [Figure 5]; 
and HDDs at the posterior pole (N = 43, 80%) [Figure 3]. 
In each 27 (50%) eyes, we detected more than 30 HDDs. 
Early stromal vessel hyperfluorescence at the posterior 
pole was observed in 25 (46%) eyes [Figure 3], optic 
disc hyperfluorescence in 15 (28%) eyes [Figure 3], and 
hyperfluorescent peripheral pinpoints in 11 (20%) eyes 
[Figure 3]. Figure 6 shows the distribution of ICGA 
lesions.
Notably, in most instances, retinal and choroidal 
lesions occurred independently of each other—i.e., a 
retinal FA lesion did not correspond to a choroidal 
ICGA lesion and vice versa. This indicated dual random 
independent involvement of the retina and choroid. We 
further analyzed the evolution of the FA/ICGA scores.
Before and after treatment, the mean FA score 
changed from 6.97±5.08 to 3.63±3.14 (P = 0.004) and 
the mean ICGA score decreased from 13.48±7.06 to 
7.47±5.58 (P < 0.0001) [Figure 8, 9 and Table 1]. Figure 9 
shows also the evolution of the angiographic scores and 
Table 1 shows the evolution of individual angiographic 
signs. Post‑treatment angiography was obtained at a 
mean follow‑up time of 9.2 ± 5.39 months and final 
follow‑up angiography was obtained after a mean 
follow‑up of 23 ± 23.11 months. In 2 out of 28 patients 
ATT had to be stopped early after 5 and 6 months due 
to gastrointestinal disturbance and a general ill‑feeling. 
Despite discontinuing of ATT, no recurrence was noted.
DISCUSSION
Ocular tuberculosis represents a substantial diagnostic 
challenge in areas that are non‑endemic for TB.[28,29] 
While testing for infectious agents often yields 
positive results in more endemic areas, the diagnostic 
elements and criteria in non‑endemic areas remain 
unsatisfactory. In non‑endemic regions, ocular lesion 
Figure 1. Distribution of eyes (N = 54) according to 
preponderant involvement: choroid > retina; retina > choroid; 
or retina = choroid.
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severity is often less pronounced as evidenced in 
our series where no fundus lesions were observed in 
five of the 28 patients. Thus, there remains a need to 
Figure 2. Example of discrepancy between choroidal and retinal involvement, with simultaneously acquired frames showing 
quasi‑absent retinal involvement (background inflammation score of 3/40) and severe choroidal involvement with an indocyanine 
green angiography score of 22/40.
Table 1. Pre-treatment, during-treatment, post-treatment and last-treatment scores of the 2 most frequent fluorescein 
angiographic (FA) and indocyanine green angiographic (ICGA) signs (* = P < 0.05; in relation with pre-treatment)
Mean score
pre-treatment during treatment post-treatment last angiography
FA
Disc hyperfluorescence 1.46±0.89 1.25±0.9* 0.71±0.67* 0.81±0.7*
Peripheral capillary leakage at 5‑10 min 2.19±2.19 1.94±1.89* 1.11±1.97* 1.19±2.01*
ICGA
Fuzziness/exudation of choroidal vessels 1.62±1.16 0.83±0.62* 1.62±1.24* 1.31±1.44*
Hypofluorescent dark dots in the mid‑periphery 
and periphery
2.44±1.5 1.83±1.54* 2.24±1.01* 1.62±1.39*
* = P < 0.05; in relation with pre‑treatment
Figure 3. (a) Fluorescein angiography showing disc 
hyperfluorescence (optic disc score of 3/3). (b) ICGA showing 
hyperfluorescence of the optic disc (score of 3/3). (c) ICGA 
showing posterior pole dark dots (score of 2/2). (d) ICGA 
showing early stromal hyperfluorescence at the posterior 
pole (score of 1/1). (e) ICGA showing hyperfluorescent 
pinpoints (score of 3/3). ICGA, indocyanine green 
angiography.
a
b c d
e
Figure 4. Fluorescein angiography showing macular 
hyperfluorescence (score of 4/4), capillary leakage in the 
periphery (small black arrows; score of 8/8) and at the posterior 
pole (large black arrows; score of 2/2). There is also detectable 
retinal vascular staining and leakage in the periphery (small 
white arrows; score of 4/4) and at the posterior pole (large 
white arrows; score of 1/3).
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Figure 5. Fluorescein angiography showing NVE (score of 
2/2) and retinal capillary non‑perfusion (score of 4/6). NVE, 
neovascularization elsewhere.
Figure 6. Left: Distribution of lesions seen on FA before anti‑tuberculous treatment. Right: Distribution of lesions seen on ICGA 
before anti‑tuberculous treatment. FA, fluorescein angiography; ICGA, indocyanine green angiography; NVD, neovascularization 
of the optic disc; NVE, neovascularization elsewhere.
improve our diagnostic abilities by integrating new 
diagnostic modalities, such as interferon‑gamma 
release assays (IGRAs).[30‑36]
Our present results showed that tuberculous 
chorioretinitis could involve retinal and choroidal structures 
independently, such that lesions in one compartment 
were not necessarily the consequence of lesions from the 
other compartment. These findings indicate that ocular 
tuberculosis can involve all eye structures at random, as 
casualties of a systemic disease.[4,9,37] This is in contrast to 
Vogt‑Koyanagi‑Harada disease, in which the inflammation 
is exclusively generated within the choroidal stroma, and 
lesions in the other structures result from spill‑over of 
choroidal inflammation.[38,39]
The presently applied dual FA/ICGA scoring system 
also revealed that choroiditis was predominant over 
retinitis with regard to both intensity (ICGA scores 
were almost double the FA scores) and proportion of 
cases (two‑thirds of examined eyes showed greater 
choroidal involvement). This indicates that investigations 
relying on FA alone without ICGA may underestimate 
ocular involvement, potentially leading to misdiagnosis. 
Indeed, twice as many patients would have been 
misdiagnosed if they have been examined with FA alone 
as compared to with ICGA alone. Our findings suggest 
that if only one type of angiography is to be performed, 
ICGA is more rewarding.
In the absence of any better quantitative measurement 
of retinal and choroidal inflammation, it is reasonable 
to consider dual FA/ICGA scoring as a reliable marker.
We further determined details regarding individual 
lesion types and their frequency in this pathology. We 
found that fuzziness/exudation of choroidal vessels 
was the most frequent ICGA feature, followed by HDDs 
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Figure 8. Improvement of the lesions on indocyanine green angiography after anti‑tuberculous treatment. Choroidal vessels 
were barely recognizable before treatment (left sextet of frames), and became more distinct after therapy (right sextet of 
frames).
disc, macular hyperfluorescence, and capillary leakage 
in the periphery in over three‑fourths of cases.
Identification of such dual angiographic features in 
a patient will lead the clinician to suspect tuberculous 
chorioretinitis, prompting the performance of 
investigational tests (e.g., PPD and/or IGRA) the results 
of which may suggest a diagnosis of presumed ocular 
tuberculosis. Furthermore, dual FA/ICGA can provide 
global information on the chorioretinal inflammation at 
each time‑point. We found that the FA and ICGA scores 
each decreased with treatment. Overall, dual FA/ICGA 
appraisal appears to provide the best global information, 
and likely represents the best modality for reaching a 
diagnosis and performing follow‑up of this pathology.
In conclusion, our present results are the first report 
of the respective contributions of retina and choroid in 
POT. We found preferential involvement of the choroid 
for which ICGA is the examination of choice. In cases of 
compatible uveitis with positive results of an IGRA test, 
particularly in a region that is non‑endemic for TB, dual 
FA and ICGA should be performed to help establish the 
diagnosis of ocular tuberculosis and improve follow‑up.
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